Press Release Title Background

NIR Raman Spectroscopy Market to grow at a CAGR of 12.39% during 2025 to 2035; Driven by Rising Demand for Advanced Analytical Testing and Increasing Adoption of Raman Spectroscopy Technologies

Report Details:
15 Companies Covered
127 Pages

Market Highlights


The NIR Raman Spectroscopy Market Size was estimated at 3510.8 USD Million in 2024. The market is projected to grow from 3986.02 in 2025 to 12740.74 by 2035, exhibiting a compound annual growth rate (CAGR) of 12.39% during the forecast period 2025 - 2035.


The global NIR and Raman spectroscopy market is expected to register a 11.72% CAGR during the forecast period, 2022–2030. The global market is developing due to the increase in the prevalence of chronic diseases, growing demand for Process Analytical Technology (PAT) tools, and technological advancements in NIR and Raman spectroscopy.


Moreover, the rising demand for cloud-based spectroscopy will provide growth opportunities for the market in the future. However, the shortage of skilled and experienced professionals might hamper the market's growth in the forecast period.


MRFR recognizes the following companies as the key players in the global NIR and Raman spectroscopy market— Thermo Fisher Scientific Inc. (US), Bruker (US), PerkinElmer Inc. (US), Agilent Technologies, Inc. (US), JASCO (Spain), Shimadzu Corporation (Japan), Danaher (US), Merck KGaA (Germany), ABB (Sweden), and Horiba, ltd (Japan).


Segment Analysis


The global NIR and Raman spectroscopy market is mainly segmented into product and aplication. On the basis of product, the market has been segmented into near-infrared spectroscopy and raman spectroscopy. On the basis of aplication, the market has been segmented into pharmaceutical applications, biotechnology &, biopharmaceutical applications, food & beverage testing environment testing, academic research, and others.


Regional Analysis


The global NIR and Raman spectroscopy market has been segmented on the basis of region into North America, Europe, Asia-Pacific, and Rest of the World.


The market growth in North America is attributed to the high prevalence of various chronic diseases, including cancer, diabetes & cardiovascular disorders, and rising healthcare expenditure. The American Cancer Society estimated that 1.9 million new cancer cases would be diagnosed and 609,360 cancer-related deaths in 2024 in the US.


Similarly, according to the data published by World Health Organization (WHO), in 2020, 2,281,685 new cancer cases were registered in the US 2020. On the other hand, Canada accounted for 274,364 new cancer cases in 2020. Raman and NIR spectroscopy is widely used in PAT applications as these techniques are non-destructive analytical techniques that are capable of analyzing materials in their current state without sample preparation (without dissolving the materials).


Near-infrared spectroscopy has gained significant attention in the region as a simple, fast, portable, non-invasive, and inexpensive method for functional diagnosis and therapeutic monitoring of cancer diseases.


The increasing prevalence of chronic diseases, rising geriatric population, and NIR and Raman spectroscopy technological advancements drive market growth. An article published by Population Reference Bureau (PRB) in 2019 stated that Asia and Europe are the home to the world’s oldest populations, aged 65 and above. Japan (28%) registered the highest geriatric population, followed by Italy (23%), Finland, Portugal & Greece (22%), and China (12%). In addition, the countries in the southern European region, including Croatia, Malta, Portugal, Greece, Italy, Slovenia, Serbia, and Spain, accounted for 21% of the population aged 65 and above.


Key Findings of the Study



  • Technological advancements are enhancing the capabilities and applications of NIR Raman spectroscopy.

  • The demand for portable spectroscopic devices is rising, particularly in field applications and remote analysis.

  • Integration of AI and machine learning is streamlining data analysis and improving accuracy in results.

  • Growing applications in pharmaceuticals and rising demand in food safety and quality control are key drivers of market expansion.